Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
Admitted local publications that cite A phase 2 study of venetoclax plus azacitidine as induction therapy in fit middle-aged patients with newly diagnosed acute myeloid leukemia.